Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Carpenter

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|November 13, 2009
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulationErica L Carpenter, Rosemarie Mick, Jens Rüter, et al.
JAMA Oncology|May 13, 2022
Biomarker Testing, Treatment Uptake, and Survival Among Patients With Urothelial Cancer Receiving Gene-Targeted TherapyVivek Nimgaonkar, Rebecca A Hubbard, Erica L Carpenter, et al.
British Journal of Cancer|October 3, 2023
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumorsJeffrey C Thompson, Dylan G Scholes, Erica L Carpenter, et al.
Scientific Reports|August 16, 2023
Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex mediaAndrew A Lin, Hanfei Shen, Griffin Spychalski, et al.
Research Square|June 9, 2023
Parallelized immunomagnetic nanopore sorting: modeling, scaling, and optimization of surface marker specific isolation of extracellular vesicles from complex mediaAndrew A Lin, Hanfei Shen, Griffin Spychalski, et al.
The Oncologist|July 3, 2021
Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung CancerJhanelle Gray, Jeffrey C Thompson, Erica L Carpenter, et al.
Journal of Neuroimmunology|December 7, 2007
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degenerationErica L Carpenter, Barbara A Vance, Rachel S Klein, et al.
Frontiers in Medicine|November 19, 2021
Racial Disparities in 30-Day Outcomes Following Index Admission for COVID-19Vivek Nimgaonkar, Jeffrey C Thompson, Lauren Pantalone, et al.
JCI Insight|January 26, 2021
Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patientsMax M Wattenberg, Veronica M Herrera, Michael A Giannone, et al.
JCI Insight|September 2, 2025
Cell-free DNA methylomics identify tissue injury patterns in pediatric ARDSNadir Yehya, Jacob E Till, Nishi Srivastava, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|November 13, 2009
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulationErica L Carpenter, Rosemarie Mick, Jens Rüter, et al.
JAMA Oncology|May 13, 2022
Biomarker Testing, Treatment Uptake, and Survival Among Patients With Urothelial Cancer Receiving Gene-Targeted TherapyVivek Nimgaonkar, Rebecca A Hubbard, Erica L Carpenter, et al.
British Journal of Cancer|October 3, 2023
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumorsJeffrey C Thompson, Dylan G Scholes, Erica L Carpenter, et al.
Scientific Reports|August 16, 2023
Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex mediaAndrew A Lin, Hanfei Shen, Griffin Spychalski, et al.
Research Square|June 9, 2023
Parallelized immunomagnetic nanopore sorting: modeling, scaling, and optimization of surface marker specific isolation of extracellular vesicles from complex mediaAndrew A Lin, Hanfei Shen, Griffin Spychalski, et al.
The Oncologist|July 3, 2021
Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung CancerJhanelle Gray, Jeffrey C Thompson, Erica L Carpenter, et al.
Journal of Neuroimmunology|December 7, 2007
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degenerationErica L Carpenter, Barbara A Vance, Rachel S Klein, et al.
Frontiers in Medicine|November 19, 2021
Racial Disparities in 30-Day Outcomes Following Index Admission for COVID-19Vivek Nimgaonkar, Jeffrey C Thompson, Lauren Pantalone, et al.
JCI Insight|January 26, 2021
Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patientsMax M Wattenberg, Veronica M Herrera, Michael A Giannone, et al.
JCI Insight|September 2, 2025
Cell-free DNA methylomics identify tissue injury patterns in pediatric ARDSNadir Yehya, Jacob E Till, Nishi Srivastava, et al.
Pageof 9